Evidence map›Paper›PMID 30032486›Full record

ArticleMolecular genetics & genomic medicine2018

JAK3 mutations in Italian patients affected by SCID: New molecular aspects of a long-known gene.

Gigliola Di Matteo, Maria Chiriaco, Alessia Scarselli, Cristina Cifaldi, Susanna Livadiotti, Silvia Di Cesare, Valentina Ferradini, Alessandro Aiuti, Paolo Rossi, Andrea Finocchi and 1 more

Open access · goldAbstract readCase Reports
In one paragraph

Article in Molecular genetics & genomic medicine, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.8field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 15 citations in OpenAlex.

  1. Identification of novelFrontiers in genetics · 2026
    Article
  2. Case report: A novelFrontiers in immunology · 2024
    Article
  3. Review
  4. Review
  5. Whole-exome sequencing of TClinical and experimental immunology · 2021
    Article
  6. Mutations inFrontiers in oncology · 2021
    Article
  7. Review
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Gigliola Di MatteoDepartment of Systems Medicine, University of Rome Tor Vergata, Rome, Italy.ORCID 0000-0001-8344-5635
Maria ChiriacoDepartment of Pediatrics, Children's Hospital Bambino Gesù, Rome, Italy.
Alessia ScarselliDepartment of Pediatrics, Children's Hospital Bambino Gesù, Rome, Italy.
Cristina CifaldiDepartment of Pediatrics, Children's Hospital Bambino Gesù, Rome, Italy.
Susanna LivadiottiDepartment of Pediatrics, Children's Hospital Bambino Gesù, Rome, Italy.
Silvia Di CesareDepartment of Pediatrics, Children's Hospital Bambino Gesù, Rome, Italy.
Valentina FerradiniDepartment of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy.
Alessandro AiutiSan Raffaele Telethon Institute for Gene Therapy (SR-TIGET), Pediatric Immunohematology Unit, San Raffaele Scientific Institute, Milan, Italy.
Paolo RossiDepartment of Systems Medicine, University of Rome Tor Vergata, Rome, Italy.
Andrea FinocchiDepartment of Systems Medicine, University of Rome Tor Vergata, Rome, Italy.
Caterina CancriniDepartment of Systems Medicine, University of Rome Tor Vergata, Rome, Italy.
Bambino Gesù Children's Hospital · ITUniversity of Rome Tor Vergata · ITVita-Salute San Raffaele University · IT

Funding

Ospedale Pediatrico Bambino Gesù Ricerca Corrente 201602PI003708The Italian Ministero della Salute (Programma di rete) NET-2011-02350069
6 · The paper itself

Abstract

backgroundMutations in the Janus Kinase 3 (JAK3) gene cause an autosomal recessive form of severe combined immunodeficiency (SCID) usually characterized by the absence of both T and NK cells, but preserved numbers of B lymphocytes (T-B+NK-SCID). The detection of larger (>100 bp) genomic duplications or deletions can be more difficult to be detected by PCR-based methods or standard NGS protocols, and a broad range of mutation detection techniques are necessary.

methodsWe report four unrelated Italian patients (two females and two males) with SCID phenotype. Protein expression, functional studies, molecular analysis by standard methods and NGS, and transcripts studies were performed to obtain a definitive diagnosis.

resultsHere, we describe four JAK3-deficient patients from four unrelated families. The first patient is homozygous for the known c.1951 C>T mutation causing the amino acidic change p.R651W. The other two patients, originating from the same small Italian town, resulted compound heterozygotes for the same g.15410_16542del deletion and two different novel mutations, g.13319_13321delTTC and c.933T>G (p.F292V), respectively. The fourth patient was compound heterozygous for the novel mutations p.V599G and p.W709R. Defective STAT5 phosphorylation after IL2 or IL15 stimulation corroborated the mutation pathogenicity. Concerning g.15410_16542del mutation, probably due to an unequal homologous recombination between Alu elements of JAK3 gene, microsatellites analysis revealed that both unrelated Pt2 and Pt3 and their carrier family members shared the same haplotype. These data support the hypothesis of a founder effect for the g.15410_16542del mutation that might have inherited in both unrelated families from the same ancient progenitor.

conclusionDifferent molecular techniques are still required to obtain a definitive diagnosis of AR-SCID particularly in all cases in which a monoallelic mutation is found by standard mutation scanning methods.

Indexed as

Base SequenceMutation, MissenseSequence DeletionAmino Acid SubstitutionFemaleHumansInfantInfant, NewbornItalyJanus Kinase 3MaleX-Linked Combined Immunodeficiency DiseasesJAK3 protein, humanJanus Kinase 3Alu repeats recombinationfounder effectJAK3 novel mutationsSCID

Identifiers

PMID30032486
PMCPMC6160700
OpenAlexW2883107332

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.